Kurzweil predicted three enabling technologies and the death of print. Three arrived. Print didn’t die.
Kurzweil pointed at the wrong telescope, the wrong observatory, the wrong funder — and the right capability.
Kurzweil bet three cosmic footnotes against the next 20 years of physics. Black holes paid. Webb’s quasar lines and the Jafferis wormhole did not.
Kurzweil’s 2005 footnote on dendritic spines turned out to be load-bearing — and the same biology now writes English from inside a paralyzed patient’s cortex.
A frozen-cell line from 1980 produced a living foal in 2020. The Tasmanian tiger claim Kurzweil leaned on collapsed the same year his book published.
The three most-valuable US humanoid startups together hold eight issued US patents. Hyundai’s Boston Dynamics holds 131. UBTech holds 193. The map of who’s filing looks nothing like the map of who’s funded.
Six approved siRNA drugs and zero of them treat infection or cancer. The COVID lab tested every prediction in Kurzweil’s biosecurity chapter, and the molecule he championed won the wrong race.
Solar modules really are about as cheap as newspaper. They just didn’t get there through Drexler’s molecular assemblers — they got there through Chinese silicon factories and perovskite tandems.
Schlumberger filed nine U.S. lithium patents in 2025. Exxon just produced its first battery-grade lithium. The oilfield is becoming the lithium field, and the patent docket has been telling the story since 2022.
Solar arrived ahead of Kurzweil’s schedule. The microscopic fuel cells he paired with it died in a Boston warehouse in 2013.